Search Results - "Maddox, Ewa"

Replication Study: Systematic identification of genomic markers of drug sensitivity in cancer cells by Vanden Heuvel, John P, Maddox, Ewa, Maalouf, Samar W

“…In 2016, as part of the Reproducibility Project: Cancer Biology, we published a Registered Report (Vanden Heuvel et al., 2016), that described how we intended…”
Get full text

Accumulating evidence to support the safe and efficacious use of a proprietary blend of capsaicinoids in mediating risk factors for obesity by Mariwala, Javahar Kohli, Rai, Deshanie, Padigaru, Muralidhara, Ashok Morde, Abhijeet, Maddox, Ewa, Maalouf, Samar, Smith, Kayla, Vanden Heuvel, John P.

“…Obesity is a significant public health concern, and finding safe and effective means for combating this condition is needed. This study investigates the safety…”
Get full text

A Concise Synthesis of the Pennsylvania Green Fluorophore and Labeling of Intracellular Targets with O 6 -Benzylguanine Derivatives by Mottram, Laurie F, Maddox, Ewa, Schwab, Markus, Beaufils, Florent, Peterson, Blake R

“…We report improved syntheses of the Pennsylvania Green and 4-carboxy-Pennsylvania Green fluorophores; the latter compound was prepared from methyl…”
Get full text

A concise synthesis of the Pennsylvania Green fluorophore and labeling of intracellular targets with O6-benzylguanine derivatives by Mottram, Laurie F, Maddox, Ewa, Schwab, Markus, Beaufils, Florent, Peterson, Blake R

“…We report improved syntheses of the Pennsylvania Green and 4-carboxy-Pennsylvania Green fluorophores; the latter compound was prepared from methyl…”
Get full text

A novel fibroblast growth factor 1 (FGF-1) mutant-collagen binding domain (CBD) fusion protein by Brewster, Luke P., Brey, Eric, Maddox, Ewa, Burgess, Wilson H., Greisler, Howard P.

“…Introduction: R136K is a protease-resistant mutant of the angiogen FGF-1 that was bound to a CBD to localize delivery and prolong bioavailability onto collagen…”
Get full text

Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM) by Brewster, Luke P., Brey, Eric M., Tassiopoulos, Apostolos K., Xue, Lian, Maddox, Ewa, Armistead, David, Burgess, Wilson H., Greisler, Howard P.

“…Through site-directed mutagenesis we have created a favorable fibroblast growth factor-1 (FGF-1) mutant (S130K) and linked it to a heparin-binding…”
Get full text

Effective use of Gamma Irradiation for Pathogen Inactivation of Monoclonal Antibody Preparations by Grieb, Teri, Forng, Ren-Yo, Brown, Robert, Owolabi, Timothy, Maddox, Ewa, Mcbain, Anna, Drohan, William N., Mann, David M., Burgess, Wilson H.

“…Gamma irradiation has been used for decades as an effective method of pathogen inactivation of relatively inert materials. Until recently, its application to…”
Get full text

The S130K fibroblast growth factor-1 mutant induces heparin-independent proliferation and is resistant to thrombin degradation in fibrin glue by Shireman, Paula K, Xue, Lian, Maddox, Ewa, Burgess, Wilson H, Greisler, Howard P

“…Objective: Site-directed mutagenesis is an important technique that can alter cytokine function, thereby eliciting desired responses. S130K is a mutation of…”
Get full text

Optimizing human demineralized bone matrix for clinical application by Maddox, E, Zhan, M, Mundy, G R, Drohan, W N, Burgess, W H

“…The use of human demineralized bone matrix (DBM) powder in periodontal and orthopedic applications is limited by the variability in the osteoinductive or…”
Get more information